Triazolopyridine compounds useful as kinase inhibitors

A compound of Formula I:

• and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof, wherein:
• Rl is thiazol-5-yl substituted at the 2 position with lower alkyl amino;
• and
• R2 is phenyl or phenyl substituted with one or more substituents selected from the group consisting of halo, cyano, Cl-C4 alkyl and hydroxy.